Updated November 10, 2026
The average analyst price target for DHT is $27.37 on a 12-month horizon. With the stock trading at $20.56, that leaves upside of +33.1%.
We define the fair-value range as ±10% of the price target, because price targets are estimates, not exact values. For DHT the range runs from $24.63 to $30.11 — which means the stock is considered undervalued.
Our overall score for DHT is 81/100 (value 81, quality 99, momentum 63). The price target shows where the analysts expect the price to go — our score shows how the company is doing right now. The strongest setup is when both point in the same direction.
The average analyst price target for DHT is $27.37 on a 12-month horizon. The current price is $20.56, which leaves upside of +33.1%. On that basis the stock is considered undervalued.
The fair-value range (±10% of the price target) for DHT runs from $24.63 to $30.11. The price currently sits below the range – the stock is considered undervalued.
A price target is the analysts' estimate of where the stock could be in 12 months – not a promise. Analysts often adjust their targets only after the price has already moved, so big turning points are sometimes missed. Use the price target as a reference point together with the technical signal as well as the key figures – never as a guarantee.
The price target is the average of the analysts' 12-month price targets (Wall Street consensus), refreshed daily from our data sources – together with the price, the signal, plus the key figures.
The price target is the average of the analysts' 12-month price targets (Wall Street consensus), updated daily. Analysis framework by Troels Højbjerg, the creator of WallStreetBuys. WallStreetBuys does not offer investment advice – trading stocks carries a risk of losses.